Lv4
650 积分 2022-02-25 加入
T cell engagers in autoimmune diseases
13天前
已完结
A modular platform for Sterically Masked Activated Cytokines (SMACks)
18天前
已完结
Reshape Intracellular/Extracellular pH for Enhanced Nanocatalytic Ferroptosis and cGAS‐STING Activation Induced Immunotherapy
4个月前
已完结
Aberrant promoter methylation of CTHRC1 gene and its clinicopathological characteristics in head and neck cancer
6个月前
已完结
One-year remission of therapy-resistant SLE after a single course with the bispecific CD3: BCMA antibody teclistamab, but induction of a non-infectious Crohn’s-like inflammatory bowel disease
7个月前
已完结
The role of double-negative B cells in the pathogenesis of systemic lupus erythematosus
7个月前
已完结
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS <50% and ≥50% Cohorts of the EVOKE-02 Study
8个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
8个月前
已完结
Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy
8个月前
已完结
Anti-inflammatory role of the IgA Fc receptor (CD89): From autoimmunity to therapeutic perspectives
8个月前
已完结
皖公网安备34019202002308
